Our study showed that one full-dose depot of long-acting GnRH-a per COH cycle would be more suitable and convenient for infertile couples than GnRH antagonist and short-acting GnRH-a injections during the COVID-19 pandemic because there are fewer possible incidences of potential exposure (Ren et al., 2014; Li F. et al., 2020). The gene discussed is GNRH1; the disease is Infertility.